Literature DB >> 15328760

Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.

J Armer1, M R Fu, J M Wainstock, E Zagar, L K Jacobs.   

Abstract

To compare the occurrence, signs, and symptoms of lymphedema (LE) the arms of women after axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB), combined SLNB and ALND (Both), or neither as part of breast cancer diagnosis and treatment, a concurrent descriptive-comparative cross-sectional four-group design with retrospective chart review was carried out. In a convenience sample of 102 women treated for breast cancer and receiving follow-up care at a midwestern United States cancer center, sequential circumferential measurements at five selected anatomical sites along both arms and hands were used to determine the presence of LE (> or = 2 cm differences between sites). Participants self-reported LE-related signs and symptoms by interview and completion of the Lymphedema and Breast Cancer Questionnaire (LBCQ). Retrospective chart review was carried out to verify lymph node-related diagnostic and treatment procedures. Based on node group, LE occurred as follows: 43.3% (29 of 67) of women who underwent ALND alone; 22.2% (2 of 9) of those who underwent SLNB alone; 25.0% (3 of 12) of those with combined SLNB and ALND; and 22.2% (2 of 9) with neither SLNB nor ALND. LE-related symptoms were reported by women who underwent ALND alone, SLND alone, combined SLNB and ALND, and neither. Among the node groups, three symptoms were more common: larger arm size, firmness/tightness in past year, and numbness in past year. We conclude that circumferential measurements of the upper arm and forearm may be critical for distinguishing LE from no LE. Overall, the proportion of women who experienced LE-related signs and symptoms was higher among women who underwent ALND versus SLNB. However, numbness and tenderness frequently were reported by those undergoing ALND, SLNB or both; and by women without LE. It is possible that some frequently occurring symptoms, such as numbness and tenderness, may be related to breast cancer surgery and not LE. Findings from this study can assist health professionals in educating women with breast cancer about LE risk factors, as well as early detection and management of LE by using the LBCQ and sequential circumferential arm measurements to evaluate limb changes subjectively and objectively concurrent with each breast cancer survivor's follow-up care.

Entities:  

Mesh:

Year:  2004        PMID: 15328760

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  40 in total

1.  (68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes.

Authors:  Renata Madru; Thuy A Tran; Johan Axelsson; Christian Ingvar; Adnan Bibic; Freddy Ståhlberg; Linda Knutsson; Sven-Erik Strand
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

2.  Manual Lymphatic Drainage after Subepidermal Tracer Injection Optimizes Results of Sentinel Lymph Node Labeling in Primary Breast Cancer.

Authors:  Martin Sillem; Urban Bromberger; Barbara Heitzelmann; Wolfgang J Brauer; Martin Werner; Sylvia Timme
Journal:  Breast Care (Basel)       Date:  2015-12-21       Impact factor: 2.860

Review 3.  Management of secondary lymphedema related to breast cancer.

Authors:  Oren Cheifetz; Louise Haley
Journal:  Can Fam Physician       Date:  2010-12       Impact factor: 3.275

4.  Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

Authors:  Stephanie R Land; Jacek A Kopec; Thomas B Julian; Ann M Brown; Stewart J Anderson; David N Krag; Nicholas J Christian; Joseph P Costantino; Norman Wolmark; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

5.  A pilot randomized trial evaluating low-level laser therapy as an alternative treatment to manual lymphatic drainage for breast cancer-related lymphedema.

Authors:  Sheila H Ridner; Ellen Poage-Hooper; Collin Kanar; Jennifer K Doersam; Stewart M Bond; Mary S Dietrich
Journal:  Oncol Nurs Forum       Date:  2013-07       Impact factor: 2.172

6.  Bioelectrical impedance for detecting upper limb lymphedema in nonlaboratory settings.

Authors:  Sheila H Ridner; Mary S Dietrich; Jie Deng; Candace M Bonner; Nancy Kidd
Journal:  Lymphat Res Biol       Date:  2009       Impact factor: 2.589

7.  Using temporal mining to examine the development of lymphedema in breast cancer survivors.

Authors:  Jason M Green; Sowjanya Paladugu; Xu Shuyu; Bob R Stewart; Chi-Ren Shyu; Jane M Armer
Journal:  Nurs Res       Date:  2013 Mar-Apr       Impact factor: 2.381

8.  Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.

Authors:  Kerri M Clough-Gorr; Patricia A Ganz; Rebecca A Silliman
Journal:  Breast J       Date:  2009-11-24       Impact factor: 2.431

9.  The Health Deviation of Post-Breast Cancer Lymphedema: Symptom Assessment and Impact on Self-Care Agency.

Authors:  Jane M Armer; Mary H Henggeler; Constance W Brooks; Eris A Zagar; Sherri Homan; Bob R Stewart
Journal:  Self Care Depend Care Nurs       Date:  2008

10.  Comparison of quality of life, satisfaction with surgery and shoulder-arm morbidity in breast cancer survivors submitted to breast-conserving therapy or mastectomy followed by immediate breast reconstruction.

Authors:  Renata Freitas-Silva; Délio Marques Conde; Ruffo de Freitas-Júnior; Edson Zangiacomi Martinez
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.